These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9618830)

  • 1. Comparison of in vitro activity of azithromycin and ampicillin against 31 isolates of Streptococcus milleri.
    Kaneko A; Sasaki J
    Tokai J Exp Clin Med; 1997 Sep; 22(3):99-102. PubMed ID: 9618830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.
    Dorfman MS; Wagner RS; Jamison T; Bell B; Stroman DW
    Adv Ther; 2008 Mar; 25(3):208-17. PubMed ID: 18369536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
    Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains.
    Tracy M; Wanahita A; Shuhatovich Y; Goldsmith EA; Clarridge JE; Musher DM
    Antimicrob Agents Chemother; 2001 May; 45(5):1511-4. PubMed ID: 11302819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia.
    Alou L; Giménez MJ; Sevillano D; Aguilar L; Cafini F; Echeverría O; Pérez-Trallero E; Prieto J
    J Antimicrob Chemother; 2006 Aug; 58(2):349-58. PubMed ID: 16782744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin iv pharmacodynamic parameters predicting Streptococcus pneumoniae killing in epithelial lining fluid versus serum: an in vitro pharmacodynamic simulation.
    Sevillano D; Alou L; Aguilar L; Echevarría O; Giménez MJ; Prieto J
    J Antimicrob Chemother; 2006 Jun; 57(6):1128-33. PubMed ID: 16617063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of time and temperature on inactivation of aminoglycosides by ampicillin at neonatal dosages.
    Daly JS; Dodge RA; Glew RH; Keroack MA; Bednarek FJ; Whalen M
    J Perinatol; 1997; 17(1):42-5. PubMed ID: 9069064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bacterial sensitivity test to determine the effectiveness of minocycline HCI (Minocin), erythromycin (Erythrocin) and ampicillin (Ampicin) on the predominant microorganisms present in a diseased periodontium.
    Angeles BL; Book DR; Go KG; Lim DJ; Uy HG
    J Philipp Dent Assoc; 1994; 46(1):4-12. PubMed ID: 9462063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibility to macrolide antibiotics of Bordetella pertussis and Bordetella parapertussis strains isolated from whooping cough patients in 1968 and in 1997-99].
    Chodorowska M; Kuklińska D; Tyski S
    Med Dosw Mikrobiol; 2001; 53(1):39-43. PubMed ID: 11757403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surveillance of antimicrobial susceptibility of Haemophilus influenzae isolates from children in Beijing, Shanghai, and Guangzhou 2000 - 2002].
    Shen XZ; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Jiang M; Hu YY; Yang YH
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1335-9. PubMed ID: 15387940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance and minimum inhibitory concentrations of bacteria isolated from bustards in the United Arab Emirates.
    Bailey TA; Silvanose C; Wernery U; Samour JH; Naldo J
    Avian Dis; 1998; 42(4):690-7. PubMed ID: 9876837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activity of moxifloxacin against multidrug-resistant Streptoccocus pneumoniae at clinically achievable serum and epithelial lining fluid concentrations compared with three other antimicrobials.
    Cafini F; Alou L; Sevillano D; Valero E; Prieto J;
    Int J Antimicrob Agents; 2004 Oct; 24(4):334-8. PubMed ID: 15380257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of orally administered azithromycin in various blood compartments.
    Wildfeuer A; Laufen H; Zimmermann T
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):356-60. PubMed ID: 7952797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin.
    Koeth LM; Good CE; Saunders KA; Jakielaszek C
    Int J Antimicrob Agents; 2004 Aug; 24(2):144-9. PubMed ID: 15288313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the antibacterial activity in vitro of various antibiotic associations].
    Pisano E; Pagano G; Iannelli S; Pellegrini A
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1967; 60(9):407-17. PubMed ID: 5606356
    [No Abstract]   [Full Text] [Related]  

  • 17. In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum.
    Biswas S
    J Postgrad Med; 2001; 47(4):240-3. PubMed ID: 11832638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibility of Campylobacter jejuni clinical isolates from children to eight antibiotics].
    García-Campos JA; Alarcón T; Domingo D; Menéndez-Rivas M; López-Brea M
    Rev Esp Quimioter; 2003 Jun; 16(2):216-20. PubMed ID: 12973460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
    Jones RN; Critchley IA; Whittington WL; Janjic N; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):311-7. PubMed ID: 16269221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains.
    Treyaprasert W; Schmidt S; Rand KH; Suvanakoot U; Derendorf H
    Int J Antimicrob Agents; 2007 Mar; 29(3):263-70. PubMed ID: 17194570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.